Get my own profile
Public access
View all26 articles
4 articles
available
not available
Based on funding mandates
Co-authors
- Anastasia KhvorovaUMASS Medical SchoolVerified email at umassmed.edu
- Andrew ColesUniversity of Massachusetts Medical schoolVerified email at umassmed.edu
- Dimas EcheverriaAssoc Director of Nucleic Acid Chemistry Center, UMass Medical SchoolVerified email at umassmed.edu
- Matthew HasslerUmass Medical SchoolVerified email at mail.mcgill.ca
- Marie DidiotUniversity of Massachusetts Medical SchoolVerified email at umassmed.edu
- Bruno M.D.C. GodinhoAtalanta TherapeuticsVerified email at atalantatx.com
- Julia AltermanUniversity of Massachusetts Medical SchoolVerified email at umassmed.edu
- Annabelle BiscansAstraZeneca R&D, SwedenVerified email at astrazeneca.com
- Maire F. OsbornRNA Therapeutics Institute | Univ. of Massachusetts Medical SchoolVerified email at umassmed.edu
- Michelle DubukeUMass Medical SchoolVerified email at umassmed.edu
- Socheata LySenior Scientist, ReNAgade TherapeuticsVerified email at renagadetx.com
- Steptoe AUniversity College LondonVerified email at ucl.ac.uk
- Samantha DockrayUniversity College CorkVerified email at ucc.ie
- Melissa J. MooreModerna Therapeutics/UMass Medical SchoolVerified email at umassmed.edu
- Jonathan K. WattsProfessor, RNA Therapeutics Institute, UMass Chan Medical SchoolVerified email at umassmed.edu
- Vivek SharmaUniversity of Massachusetts Chan Med School, USAVerified email at umassmed.edu
- Gregory S Thomas, MD, MPHMedical Director Emeritus, Cardiovascular Program Development, MemorialCare Heart & VascularVerified email at memorialcare.org